Apparatus and methods for magnetic separation featuring external magnetic means

• US 5,466,574 A
• Filed: 01/15/1993
• Issued: 11/14/1995
• Est. Priority Date: 03/25/1991
• Status: Expired due to Fees

• Current Assignee: Veridex LLC (Johnson & Johnson)
• Original Assignee: Immunivest Corporation
• Inventors: Tang, Weixin, Gohel, Dhanesh I., Liberti, Paul A., Wang, Yuzhou, Feeley, Brian P.
• Primary Examiner(s): Scheiner, Toni R.
• Assistant Examiner(s): Wolski, Susan C.
• Application Number:
  US08/006,071
• Time in Patent Office: 1,033 Days
• Field of Search: 435/2, 435/5, 435/7.2, 435/7.21, 435/7.25, 435/7.32, 435/7.5, 435/7.9, 435/7.92, 435/7.94, 435/971, 436/525, 436/526, 436/528, 436/531, 436/534, 436/807, 436/824, 436/827, 436/828, 209/214, 209/223.1, 210/222, 210/695
• US Class Current: 435/5
• CPC Class Codes: A23L 3/32 by treatment with electric currents without heating effect
• CPC Class Codes: B03C 1/035 Open gradient magnetic separators, i.e. separators in which the gap is unobstructed, characterised by the configuration of the gap
• CPC Class Codes: B03C 1/286 disposed at the inner circumference of a recipient, e.g. magnetic drain bolt
• CPC Class Codes: B03C 2201/18 Magnetic separation whereby the particles are suspended in a liquid
• CPC Class Codes: B03C 2201/26 for use in medical applications
• CPC Class Codes: G01N 33/54326 Magnetic particles
• CPC Class Codes: G01N 35/0098 involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation magnetic particles used in immunoassays G01N33/54326; magnetic separation in general B03C
• CPC Class Codes: Y10S 435/971 Capture of complex after antigen-antibody reaction
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures
• CPC Class Codes: Y10S 436/824 Immunological separation techniques
• CPC Class Codes: Y10S 436/827 Lectins
• CPC Class Codes: Y10S 436/828 Protein A

Abstract

A magnetic separator for isolating magnetically-labeled substances of interest, such as immunological agents, from a non-magnetic test medium using a method of high gradient magnetic separation. The target substance is contacted with microscopic magnetic particles having a receptor for binding with the target substance. The test medium containing the magnetic particles is held in a non-magnetic container and placed into a gap within an arrangement of magnets for causing the magnetic particles to adhere to selected locations upon the interior wall of the container. The quantity of magnetic particles may be controlled to cause the magnetic particles collected upon the interior wall to form a monolayer. The magnets are arranged upon a yoke which may provide linear, surrounding multipolar, or partially surrounding multipolar configurations of magnetic pole faces about the gap. The magnetic pole faces may be of differing cross-sectional areas to enhance the magnetic field gradient in regions adjacent to the smaller pole faces. The method and apparatus may be used for such investigations as enzyme-labeled competitive immunoassay and "sandwich" immunoassays.

Claims

1. A method for magnetically separating a target substance from a non-magnetic test medium in a magnetic separator comprising a container having a peripheral wall and magnetic means positioned outside of said container, the method comprising the steps of:

a) contacting a quantity of magnetic particles having a receptor thereon which specifically binds to said target substance with said test medium, resulting in target substance-bearing magnetic particles;

b) introducing said test medium containing said magnetic particles into said container; and

c) positioning said container holding said test medium with the peripheral wall of said container adjacent to said magnetic means;

d) generating, in said test medium, a magnetic field that is substantially uniform along said peripheral wall and having a gradient in which the magnetic field is stronger in the test medium adjacent to said wall of the container than in the test medium more distant from the wall and is operative upon the magnetic particles to attract said magnetic particles toward said wall and cause such particles to be adhered to said wall, and

e) controlling the quantity of magnetic particles introduced into said container relative to the surface area of said wall exposed to the test medium and controlling the orientation of the exposed surface area relative to said magnetic means, thereby to cause adherence of said particles to the exposed wall surface in a substantially single layer to substantially prevent entrapment of interfering substances.

2. A method as claimed in claim 1 including the step of maintaining the magnetic particles adhered to the exposed wall surface of said container while removing the non-magnetic test medium from said container.

3. A method as claimed in claim 2 including the step of washing the magnetic particles adhered to said exposed wall surface to remove residual test medium from said magnetic particles and from said container.

4. A method as claimed in claim 3 including the step of introducing into said container a resuspension medium and subjecting said container to conditions causing removal of said magnetic particles from said exposed surface and resuspension of said magnetic particles in said resuspension medium.

5. The method of claim 1 wherein said positioning step comprises translating said container horizontally into a position adjacent to said magnetic means.

6. A method for separating magnetic particles from a fluid containing same, said method comprising:

a) introducing said fluid into a non-magnetic container having a peripheral wall and an open top;

b) positioning said container adjacent to a magnetic means producing a magnetic field gradient in said fluid, said magnetic field being stronger in said fluid adjacent to said wall than in the fluid most distant from said wall, said magnetic field being produced by positioning a plurality of magnets facing the container and around the periphery of said container such that said magnets face the container with alternating polarity producing a substantially uniform magnetic field along a portion of said peripheral wall;

c) collecting a substantially uniform layer of said particles on a broad portion of said peripheral wall in accordance with said substantially uniform magnetic field along said peripheral wall; and

d) removing said fluid from said container separately from the magnetic particles adhering to said wall while said container is positioned adjacent said magnetic means.

7. A method according to claim 6, further comprising controlling said quantity of magnetic particles in said introduced fluid relative to the surface area of said wall exposed to said test medium to cause said magnetic particles to adhere to said exposed surface in a substantially single layer to substantially prevent entrapment of interfering substances.

8. A method according to claim 6, wherein said magnetic particles comprise a transition metal oxide coated with a biofunctional polymer having available coordination sites, and having a size rendering said magnetic particles resuspendable in a colloidal suspension.

9. A method according to claim 8, wherein said transition metal oxide is magnetite and said biofunctional polymer is a protein or a polymer capable of being coupled to a protein.

10. A method according to claim 6, which is performed batchwise.

11. The method of claim 6 wherein said positioning step comprises translating said container horizontally into a position adjacent to said magnetic means.

12. A method for determining the presence or quantity of an immunoreactive ligand in a test medium suspected of containing said ligand, said method comprising:

a) contacting said test medium with a quantity of colloidal magnetic particles comprising a first receptor thereon which specifically binds to said ligand, and with a second, enzyme-linked receptor which specifically binds to said ligand, under conditions causing binding of both said receptors to said ligand, resulting in magnetic particles bearing both enzyme and ligand;

b) introducing said test medium into a non-magnetic container having a peripheral wall;

c) positioning said container adjacent to a magnetic means for generating a high gradient magnetic field in said test medium, said magnetic field being stronger in said test medium adjacent to said wall than in said test medium most distant from the wall and operative upon said magnetic particles to cause said particles to adhere to said wall, said magnetic means comprising a plurality of magnets facing the container and positioned around at least a portion of the periphery of said container;

d) removing said test medium from said container while said magnetic particles remain adhered to the wall of said container;

e) washing said magnetic particles while said particles remain adhered to said wall to remove unbound substances therefrom; and

f) determining the activity of said enzyme bound to said particles, as a measure of the presence or quantity of said ligand in said test sample.

13. A method as claimed in claim 12 wherein said ligand is an antigen and said first and second receptors are antibodies capable of specific interaction with said antigen.

14. A method as claimed in claim 13, wherein said antigen is a cell-surface antigen.

15. A method according to claim 12, wherein said determination of ligand comprises contacting said enzyme with a chromogenic substance producing a detectable color and detecting the appearance or relative intensity of said color by reference to a standard.

16. A method according to claim 15, wherein detecting the activity of said enzyme is performed with said magnetic particles adhered to said container wall.

17. A method according to claim 12, wherein said quantity of magnetic particles is controlled, relative to the exposed surface area of the wall of the container and the orientation of said exposed surface area is controlled relative to said magnetic means, so as to cause said enzyme and ligand bearing magnetic particles to adhere to said exposed wall surface in a sufficiently thin layer to substantially prevent entrapment of interfering substances.

18. A method according to claim 12, wherein determination of the activity of said enzyme is conducted with said magnetic particles immobilized on said container wall.

19. A method according to claim 12 wherein the ligand comprises Ig and the first receptor is selected from the group consisting of Protein A and Protein G.

20. A method for separating a bioentity from a test sample within a non-magnetic vessel, said bioentity selected from the group consisting of cells, cell components, and viruses, having a characteristic determinant, said method comprising:

a) introducing into said test sample a reagent which specifically birds to said determinant, in an amount sufficient to bind a portion of said reagent to said determinant and to provide a remaining portion of excess reagent in said test sample;

b) introducing into said test sample, in the presence of said excess reagent, a multivalent capture agent which specifically binds to said determinant-bound reagent, thereby to form a bioentity-reagent-capture agent complex, at least one of said determinant-bound reagent and said capture agent conjugated to colloidal magnetic particles; and

c) collecting said complex from said test sample upon the interior periphery of the vessel under the influence of a high gradient magnetic field.

21. A method according to claim 20, wherein said bioentity is selected from the group consisting of eucaryotic cells, procaryotic cells, viruses, bacteria, or a mixed population thereof.

22. A method according to claim 20, wherein an antibody is introduced into said test sample as the reagent for binding to the determinant of said bioentity.

23. A method according to claim 22, wherein said antibody is a monoclonal antibody.

24. A method according to claim 22, wherein the capture agent introduced into said test sample comprises colloidal magnetic particles coated with anti-Fc.

25. A method according to claim 24, wherein said colloidal magnetic particles comprise magnetite having a particle size from about 0.01 to about 0.50 microns.

26. A method according to claim 20, wherein the reagent comprises Ig and the capture agent is selected from the group consisting of Protein A or Protein G.

27. A method according to claim 20, wherein the reagent comprises a biotin-labeled reagent and said capture agent comprises avidin.

28. A method according to claim 20, wherein the amount of reagent present in said test sample is from about 2 to about 50 times the amount required to bind to said determinant.

29. A method for separating a biological cell having a characteristic determinant from a test medium, said method comprising:

a) introducing into said medium a monoclonal antibody which specifically birds to said determinant, in an amount sufficient to bind said monoclonal antibody to said determinant and to provide excess monoclonal antibody in said test sample;

b) introducing into said test sample, in the presence of said excess monoclonal antibody, colloidal magnetic particles conjugated to anti-Fc which specifically birds to said determinant-bound monoclonal antibody, thereby to form a cell-monoclonal antibody-magnetic anti-Fc conjugate; and

c) separating said conjugate from said medium under the influence of a high gradient magnetic field.

30. A method for separating bioentity from a test sample within a non-magnetic vessel, said bioentity selected from the group consisting of cells, cell components, and viruses, having a characteristic determinant, said method comprising:

a) introducing into said test sample a reagent which specifically birds to for said determinant, in an amount sufficient to bind a portion of said reagent to said determinant and to provide a remaining portion of excess reagent in said test sample;

b) introducing into said test sample, in the presence of said excess reagent, a multivalent capture agent which specifically binds to said determinant-bound reagent, thereby to form a bioentity-reagent-capture agent complex, at least one of said determinant-bound reagent and said capture agent conjugated to colloidal magnetic particles; and

c) collecting said complex from said test sample upon a collecting surface under the influence of a high gradient magnetic field and in the presence of said excess.

31. A method according to claim 30, wherein said reagent comprises a hapten-labeled reagent and said capture agent comprises anti-hapten.

32. A method according to claim 30, wherein said reagent comprises a biotin-labelled lectin selected from the group consisting of concanavalin A, soybean agglutinin and wheat germ agglutinin and said capture agent comprises avidin.

33. A method according to claim 30, wherein said reagent comprises a hapten-labelled lectin selected from the group consisting of concanavalin A, soybean agglutinin and wheat germ agglutinin and said .capture agent comprises antihapten.

34. A method for magnetically separating a target substance from a non-magnetic test medium, comprising the steps of:

a) placing the test medium in a container having a peripheral wall;

b) attaching said target substance to colloidal magnetic particles in suspension having a binding agent thereon which specifically binds with said target substance, resulting in target substance-bearing magnetic particles;

c) producing in said test medium a high gradient magnetic field in which the magnetic field is stronger in the test medium adjacent to said wall of the container than in the test medium more distant from the wall and is operative upon the magnetic particles to attract said magnetic particles toward said wall and cause such particles to be adhered to a broad portion of said wall, and

d) controlling the quantity of magnetic particles in said suspension relative to the surface area of said broad portion of said wall and controlling the orientation of the exposed surface area relative to said magnetic means, thereby to cause adherence of said particles to said broad portion of said wall in a substantially single layer to substantially prevent entrapment of interfering substances.

35. A method for determining the presence or quantity of an immunoreactive ligand in a test medium suspected of containing said ligand, said method comprising:

a) placing the test medium into a container having a peripheral wall;

b) contacting said test medium with a quantity of colloidal magnetic particles having a first receptor thereon which specifically binds to said ligand;

c) contacting said test medium with a second receptor which specifically binds to said ligand, said second receptor having a label with a detectable characteristic;

d) producing in said test medium a high gradient magnetic field in which the magnetic field is stronger in the test medium adjacent to said wall of the container than in the test medium more distant from the wall and is operative upon the magnetic particles attached to said ligand to attract said magnetic particles toward said wall;

e) collecting said magnetic particles on a broad portion of said wall;

f) removing said test medium from said container while said magnetic particles remain adhered to the wall of said container;

g) washing said magnetic particles while said particles remain adhered to said wall to substantially remove unbound substances therefrom; and

h) detecting the detectable characteristic of said second receptor bound to said ligand, as a measure of the presence or quantity of said ligand in said test sample.

36. The method of claim 35 wherein said detectable characteristic of said label is selected from the group consisting of enzyme activity, fluorescence, radioactivity, and chemiluminescence.